Enhanced oxidative stress in haemodialysis patients receiving intravenous iron therapy - PubMed
. 1999 Nov;14(11):2680-7.
doi: 10.1093/ndt/14.11.2680.
Affiliations
- PMID: 10534512
- DOI: 10.1093/ndt/14.11.2680
Enhanced oxidative stress in haemodialysis patients receiving intravenous iron therapy
P S Lim et al. Nephrol Dial Transplant. 1999 Nov.
Abstract
Background: Iron balance is critical for adequate erythropoiesis and there remains much debate concerning the optimal timing and dosage of iron therapy for haemodialysis patients receiving recombinant human erythropoietin therapy.
Methods: In this study, we examined the influence of baseline ferritin level and intravenous infusion of 100 mg ferric saccharate on the oxidative status of the patients on maintenance haemodialysis. The levels of antioxidant enzymes and lipid peroxides were determined in erythrocytes and plasma of 50 uraemic patients on haemodialysis. These patients were divided into groups 1, 2, and 3, based on their baseline serum ferritin levels of <300, 301-600, and >601 microg/l, respectively.
Results: We found that the mean superoxide dismutase (SOD) activities in the erythrocytes were similar in the three groups of patients and did not differ from those of the age-matched controls. On the other hand, all the haemodialysis patients showed significantly higher plasma SOD activity as compared to controls. After intravenous iron infusion, group 3 patients showed the largest decrease in plasma SOD activity. The plasma glutathione peroxidase (GSHPx) activities of the patients in all three groups and the erythrocyte GSHPx activities of the patients in the groups 2 and 3 were lower than those of the healthy controls. In all three groups of patients, no difference in GSHPx activity was found before and after intravenous iron infusion. On the other hand, we found that the average baseline levels of plasma lipid peroxides of all three groups of patients were significantly higher than that of the controls. The patients in group 3 with the highest serum ferritin levels showed the highest levels of plasma lipid peroxides. More importantly, we found that after iron infusion, the patients in all three groups, particularly those in group 3, showed significantly elevated levels of plasma lipid peroxides.
Conclusion: We demonstrated that increased oxidative stress in the blood circulation of the uraemic patients on haemodialysis is exacerbated by the elevated baseline serum ferritin levels and intravenous iron infusion. The resultant oxidative damage may contribute to the increased incidence of atherosclerosis in the patients with end-stage renal disease on long-term haemodialysis.
Similar articles
-
Effect of intravenous iron sucrose on oxidative stress in peritoneal dialysis patients.
Saglam F, Cavdar C, Uysal S, Cavdar Z, Camsari T. Saglam F, et al. Ren Fail. 2007;29(7):849-54. doi: 10.1080/08860220701573566. Ren Fail. 2007. PMID: 17994454
-
Chuang CL, Liu RS, Wei YH, Huang TP, Tarng DC. Chuang CL, et al. Nephrol Dial Transplant. 2003 Feb;18(2):370-7. doi: 10.1093/ndt/18.2.370. Nephrol Dial Transplant. 2003. PMID: 12543894
-
Iron supplementation in haemodialysis--practical clinical guidelines.
Silva J, Andrade S, Ventura H, Santos JP, Colaço S, Oliveira C, Ponce P. Silva J, et al. Nephrol Dial Transplant. 1998 Oct;13(10):2572-7. doi: 10.1093/ndt/13.10.2572. Nephrol Dial Transplant. 1998. PMID: 9794562 Clinical Trial.
-
Pollak A, Hayde M, Hayn M, Herkner K, Lombard KA, Lubec G, Weninger M, Widness JA. Pollak A, et al. Pediatrics. 2001 Jan;107(1):78-85. doi: 10.1542/peds.107.1.78. Pediatrics. 2001. PMID: 11134438 Clinical Trial.
-
Potential risk for infection and atherosclerosis due to iron therapy.
Sengoelge G, Sunder-Plassmann G, Hörl WH. Sengoelge G, et al. J Ren Nutr. 2005 Jan;15(1):105-10. doi: 10.1053/j.jrn.2004.09.018. J Ren Nutr. 2005. PMID: 15648017 Review.
Cited by
-
Total and corrected antioxidant capacity in hemodialyzed patients.
Malliaraki N, Mpliamplias D, Kampa M, Perakis K, Margioris AN, Castanas E. Malliaraki N, et al. BMC Nephrol. 2003 Jul 1;4:4. doi: 10.1186/1471-2369-4-4. BMC Nephrol. 2003. PMID: 12837136 Free PMC article.
-
Angina pectoris and intensive intravenous iron treatment in hemodialysis patients.
Malindretos P, Sioulis A, Avgeriou E, Michalaki A, Roma V, Grekas D. Malindretos P, et al. Hippokratia. 2007 Jan;11(1):30-4. Hippokratia. 2007. PMID: 19582174 Free PMC article.
-
Kuo KL, Hung SC, Wei YH, Tarng DC. Kuo KL, et al. J Am Soc Nephrol. 2008 Sep;19(9):1817-26. doi: 10.1681/ASN.2007101084. Epub 2008 May 21. J Am Soc Nephrol. 2008. PMID: 18495964 Free PMC article. Clinical Trial.
-
The impact of ferritin fluctuations on stable hemoglobin levels in hemodialysis patients.
Yahiro M, Kuragano T, Kida A, Kitamura R, Furuta M, Hasuike Y, Otaki Y, Nonoguchi H, Nakanishi T. Yahiro M, et al. Clin Exp Nephrol. 2012 Jun;16(3):448-55. doi: 10.1007/s10157-011-0584-0. Epub 2012 Jan 24. Clin Exp Nephrol. 2012. PMID: 22270185
-
Oxidative Stress in Hemodialysis Pediatric Patients.
Shouman MG, Sabry S, Galal REE, Salama E, Wahby AA, Awadallah E, Selim A. Shouman MG, et al. Open Access Maced J Med Sci. 2019 Dec 10;7(23):3955-3959. doi: 10.3889/oamjms.2019.859. eCollection 2019 Dec 15. Open Access Maced J Med Sci. 2019. PMID: 32165935 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical